Seres Therapeutics sets 2024 annual meeting for April 4, 2024

Seres Therapeutics, Inc.

Record date for voting is February 12, 2024; meeting will be held virtually.
Stockholder proposals and director nominations must be received by February 9, 2024.
Deadline for compliance with universal proxy rules under Rule 14a-19 also applies.

item 8.01

Seres Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-019398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.